Cargando…
Mass screening is a key component to fight against SARS-CoV-2 and return to normalcy
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had highly transmissible and pathogenic, which caused serious economic loss and hazard to public health. Different countries have developed strategies to deal with the COVID-19 pandemic that fit their epidemiological situations, capaci...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274759/ https://www.ncbi.nlm.nih.gov/pubmed/35862506 http://dx.doi.org/10.1515/mr-2021-0024 |
_version_ | 1784745358115471360 |
---|---|
author | Feng, Zhaomin Zhang, Yi Pan, Yang Zhang, Daitao Zhang, Lei Wang, Quanyi |
author_facet | Feng, Zhaomin Zhang, Yi Pan, Yang Zhang, Daitao Zhang, Lei Wang, Quanyi |
author_sort | Feng, Zhaomin |
collection | PubMed |
description | The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had highly transmissible and pathogenic, which caused serious economic loss and hazard to public health. Different countries have developed strategies to deal with the COVID-19 pandemic that fit their epidemiological situations, capacities, and values. Mass screening combined with control measures rapidly reduced the transmission of the SARS-CoV-2 infection. The COVID-19 pandemic has dramatically highlighted the essential role of diagnostics capacity in the control of communicable diseases. Mass screening has been increasingly used to detect suspected COVID-19 cases and their close contacts, asymptomatic case, patients attending fever clinics, high-risk populations, employees, even all population to identify infectious individuals. Mass screening is a key component to fight against SARS-CoV-2 and return to normalcy. Here we describe the history of mass screening, define the scope of mass screening, describe its application scenarios, and discuss the impact and challenges of using this approach to control COVID-19. We conclude that through a comprehension screening program and strong testing capabilities, mass screening could help us return to normalcy more quickly. |
format | Online Article Text |
id | pubmed-9274759 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | De Gruyter |
record_format | MEDLINE/PubMed |
spelling | pubmed-92747592022-07-12 Mass screening is a key component to fight against SARS-CoV-2 and return to normalcy Feng, Zhaomin Zhang, Yi Pan, Yang Zhang, Daitao Zhang, Lei Wang, Quanyi Med Rev (Berl) Review The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had highly transmissible and pathogenic, which caused serious economic loss and hazard to public health. Different countries have developed strategies to deal with the COVID-19 pandemic that fit their epidemiological situations, capacities, and values. Mass screening combined with control measures rapidly reduced the transmission of the SARS-CoV-2 infection. The COVID-19 pandemic has dramatically highlighted the essential role of diagnostics capacity in the control of communicable diseases. Mass screening has been increasingly used to detect suspected COVID-19 cases and their close contacts, asymptomatic case, patients attending fever clinics, high-risk populations, employees, even all population to identify infectious individuals. Mass screening is a key component to fight against SARS-CoV-2 and return to normalcy. Here we describe the history of mass screening, define the scope of mass screening, describe its application scenarios, and discuss the impact and challenges of using this approach to control COVID-19. We conclude that through a comprehension screening program and strong testing capabilities, mass screening could help us return to normalcy more quickly. De Gruyter 2022-04-28 /pmc/articles/PMC9274759/ /pubmed/35862506 http://dx.doi.org/10.1515/mr-2021-0024 Text en © 2022 Zhaomin Feng et al., published by De Gruyter, Berlin/Boston https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. |
spellingShingle | Review Feng, Zhaomin Zhang, Yi Pan, Yang Zhang, Daitao Zhang, Lei Wang, Quanyi Mass screening is a key component to fight against SARS-CoV-2 and return to normalcy |
title | Mass screening is a key component to fight against SARS-CoV-2 and return to normalcy |
title_full | Mass screening is a key component to fight against SARS-CoV-2 and return to normalcy |
title_fullStr | Mass screening is a key component to fight against SARS-CoV-2 and return to normalcy |
title_full_unstemmed | Mass screening is a key component to fight against SARS-CoV-2 and return to normalcy |
title_short | Mass screening is a key component to fight against SARS-CoV-2 and return to normalcy |
title_sort | mass screening is a key component to fight against sars-cov-2 and return to normalcy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9274759/ https://www.ncbi.nlm.nih.gov/pubmed/35862506 http://dx.doi.org/10.1515/mr-2021-0024 |
work_keys_str_mv | AT fengzhaomin massscreeningisakeycomponenttofightagainstsarscov2andreturntonormalcy AT zhangyi massscreeningisakeycomponenttofightagainstsarscov2andreturntonormalcy AT panyang massscreeningisakeycomponenttofightagainstsarscov2andreturntonormalcy AT zhangdaitao massscreeningisakeycomponenttofightagainstsarscov2andreturntonormalcy AT zhanglei massscreeningisakeycomponenttofightagainstsarscov2andreturntonormalcy AT wangquanyi massscreeningisakeycomponenttofightagainstsarscov2andreturntonormalcy |